Proteome analysis for pathogenicity and new diagnostic markers for Aspergillus fumigatus

References

• Wilkins MR, Sanchez JR, Gooley AA, et al. Progress with proteome projects, why all proteins expressed by a genome should be identified and how to do it. Biotech Gen Eng Reviews 1995; 13: 19–50
   Web of Science ®Google Scholar
• Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4: 3665–3685
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 422: 198–207
   PubMed Web of Science ®Google Scholar
• Phizicky E, Bastiaens PIH, Zhu H, Snyder M, Fields S. Protein analysis on a proteomic scale. Nature 2003; 422: 208–215
   PubMed Web of Science ®Google Scholar
• Zhu H, Bilgin M, Snyder M. Proteomics. Annu Rev Biochem 2003; 72: 783–812
   PubMed Web of Science ®Google Scholar
• De Hoog CL, Mann M. Proteomics. Annu Rev Genomics Hum Genet 2004; 5: 267–293
   PubMed Web of Science ®Google Scholar
• Nierman WC, Pain A, Anderson MJ, Wortman JR, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 2005; 438: 1151–1156
   PubMed Web of Science ®Google Scholar
• Odds FC, Gow NAR, Brown AJP. Fungal virulence studies come of age. Genome Biol 2001; 2: 1009.1–1009.4
   Web of Science ®Google Scholar
• Brakhage AA. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. J Curr Drug Targets 2005; 6: 875–886
   PubMed Web of Science ®Google Scholar
• Fung ET, Wright Gl, Jr, Dalmasso EA. Proteomic strategies for biomarker identification: progress and challenges. Curr Opin Mol Ther 2000; 2: 643–650
   PubMed Web of Science ®Google Scholar
• Seliger B, Kellner R. Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics 2002; 2: 1641–1651
   PubMed Web of Science ®Google Scholar
• Carberry S, Doyle S. Proteomic studies in biomedically and industrially relevant fungi. Cytotechnology 2007; 53: 95–100
   PubMed Web of Science ®Google Scholar
• Kim Y, Nandakumar MP, Marten MR. Proteomics of filamentous fungi. Trends Biotechnol 2007; 25: 395–400
   PubMed Web of Science ®Google Scholar
• Kim, Y, Nandakumar, MP, Marten, MR. The state of proteome profiling in the fungal genus Aspergillus. Brief Funct Genom Proteom 2008; 7: 87–94.
   PubMedGoogle Scholar
• Kniemeyer, O, Brakhage, AA. Proteomics and its application to the human-pathogenic fungi Aspergillus fumigatus and Candida albicans. In:. AA Brakhage, Zipfel, PF. The Mycota VI–Human and Animal Relationships. Berlin; Springer, 2008, in press.
   Google Scholar
• Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007; 45: 321–346
   PubMed Web of Science ®Google Scholar
• Kniemeyer O, Lessing F, Scheibner O, Hertweck C, Brakhage AA. Optimisation of a 2-D gel electrophoresis protocol for the human-pathogenic fungus Aspergilllus fumigatus. Curr Genet 2006; 49: 178–189
   PubMed Web of Science ®Google Scholar
• Carberry S, Neville CM, Kavanagh KA, Doyle S. Analysis of major intracellular proteins of Aspergillus fumigatus by MALDI mass spectrometry: identification and characterisation of an elongation factor 1B protein with glutathione transferase activity. Biochem Biophys Res Commun 2006; 341: 1096–1104
   PubMed Web of Science ®Google Scholar
• Bruneau JM, Magnin T, Tagat E, et al. Proteome analysis of Aspergillus fumigatus identifies glycosylphosphatidylinositol-anchored proteins associated to the cell wall biosynthesis. Electrophoresis 2001; 22: 2812–2823
   PubMed Web of Science ®Google Scholar
• Asif AR, Oellerich M, Amstrong VW, et al. Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. J Proteome Res 2006; 5: 954–962
   PubMed Web of Science ®Google Scholar
• Kim KH, Brown KM, Harris PV, Langston JA, Cherry JR. A proteomic strategy to discover β-glucosidases from Aspergillus fumigatus with two-dimensional page in-gel activity assay and tandem mass spectrometry. J Proteome Res 2007; 6: 4749–4759
   PubMed Web of Science ®Google Scholar
• Philippe B, Ibrahim-Granet O, Prevost MC, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003; 71: 3034–3042
   PubMed Web of Science ®Google Scholar
• Bonnett CR, Cornish EJ, Harmsen AG, Burrit JB. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun 2006; 74: 6528–6539
   PubMed Web of Science ®Google Scholar
• Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 1982; 38: 487–495
   PubMed Web of Science ®Google Scholar
• Levitz SM, Farrell TP. Human neutrophil degranulation stimulated by Aspergillus fumigatus. J Leucocyt Biol 1990; 47: 170–175
   PubMed Web of Science ®Google Scholar
• Aguirre J, Hansberg W, Navarro R. Fungal response to reactive oxygen species. Med Mycol 2006; 44: S101–S107
   Web of Science ®Google Scholar
• Lessing F, Kniemeyer O, Wozniok I, et al. The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse model. Eukaryot Cell 2007; 6: 2290–2302
   PubMedGoogle Scholar
• Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patiens. Eur Respir J 2002; 19: 743–755
   PubMed Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609–622
   PubMed Web of Science ®Google Scholar
• De Repentigny L, Kilanowski E, Pedneault L, Boushira M. Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis. J Infect Dis 1991; 163: 1305–1311
   PubMed Web of Science ®Google Scholar
• López-Medrano R, Ovejero MC, Calera JA, Puente P, Leal F. Aspergillus fumigatus antigens. Microbiology 1995; 141: 2699–2704
   PubMed Web of Science ®Google Scholar
• Shen HD, Lin WL, Tam FM, et al. Identification of vacuolar serine proteinase as a major allergen of Aspergillus fumigatus by immunoblotting and N-terminal amino acid sequence analysis. Clin Exp Allergy 2001; 31: 295–302
   PubMed Web of Science ®Google Scholar
• Lai HY, Tam MF, Tang RB, et al. cDNA cloning and immunological characterization of a newly identified enolase allergen from Penicillium citrinum and Aspergillus fumigatus. Int Arch Allergy Immunol 2002; 127: 181–190
   PubMed Web of Science ®Google Scholar
• Gautam P, Sundaram CS, Madan T, et al. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin Experiment Allergy 2007; 37: 1239–1249
   PubMed Web of Science ®Google Scholar
• Crameri R. Epidemiology and molecular basis of the involvement of Aspergillus fumigatus in allergic disease. Contrib Microbiol 1999; 2: 44–56
   PubMedGoogle Scholar
• Kurup VP. Aspergillus antigens: which are important?. Med Mycol 2005; 43: S189–S196
   Web of Science ®Google Scholar
• Bowyer P, Denning DW. Genomic analysis of allergen genes in Aspergillus spp.: the relevance of genomics to everyday research. Med Mycol 2007; 45: 17–26
   PubMed Web of Science ®Google Scholar
• Bowyer P, Blightman O, Denning DW. Relative reactivity of Aspergillus allergens used in serological tests. Med Mycol 2006; 44: S23–S28
   PubMed Web of Science ®Google Scholar
• Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297–1306
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukaemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 1999–2205
   Web of Science ®Google Scholar
• Holdom MD, Lechenne B, Hay RJ, Hamilton AJ, Monod M. Production and characterization of recombinant Aspergillus fumigatus Cu,Zn superoxide dismutase and its recognition by immune human sera. J Clin Microbiol 2000; 38: 558–562
   PubMed Web of Science ®Google Scholar
• Weig M, Frosch M, Tintelnot K, et al. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol 2001; 39: 1721–1730
   PubMed Web of Science ®Google Scholar
• Schwienbacher M, Weig M, Thies S, Regula JT, Heesemann J, Ebel F. Analysis of the major proteins secreted by the human opportunistic pathogen Aspergillus fumigatus under in vitro conditions. Med Mycol 2005; 43: 623–630
   PubMed Web of Science ®Google Scholar
• Sarfati J, Monod M, Recco P, et al. Recombinant antigens as diagnostic markers for aspergillosis. Diagn Microbiol Infect Dis 2006; 55: 279–291
   PubMed Web of Science ®Google Scholar
• Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Amer J Respir Crit Car Med 2004; 170: 621–625
   PubMed Web of Science ®Google Scholar
• Bozza S, Gaziano R, Lipford GB, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 2002; 4: 1281–1290
   PubMed Web of Science ®Google Scholar
• Ito JI, Lyoins JM, Hong TB, et al. Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis. Infect Immun 2006; 74: 5075–5084
   PubMed Web of Science ®Google Scholar
• Pitarch, A, Jiménez, A, César Nombela, Gil, C. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol Cell Proteomics 2006; 5: 79–96.
   PubMed Web of Science ®Google Scholar
• Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993; 7: 576–580
   Web of Science ®Google Scholar
• Kiehntopf M, Siegmund R, Deufel T. Application of SELDI-TOF-mass spectrometry for biomarker identification: potentials and limitations. J Lab Med 2007; 31: 93–108
   Google Scholar
• Lescuyer P, Hochstrasser D, Rabillould T. How shall we use the proteomics toolbox for biomarker discovery?. J Proteome Res 2007; 6: 3371–3376
   PubMed Web of Science ®Google Scholar
• Hess JL, Blazer L, Romer T, et al. Immunoproteomics. J Chromat B 2005; 815: 65–75
   PubMed Web of Science ®Google Scholar
• Sydor JR, Nock S. Protein expression profiling arrays: tools for the multiplexed high-throughput analysis of proteins. Proteome Sci 2003; 1: 3
   PubMedGoogle Scholar
• Lueking A, Cahil DJ, Mullner S. Protein biochips: a new versatile platform technology for molecular medicine. Drug Discov Today 2005; 10: 789–794
   PubMed Web of Science ®Google Scholar
• Stelter S, Angenendt P, Cahill DJ, et al. Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitides infections. Proteomics 2005; 5: 2048–2055
   PubMed Web of Science ®Google Scholar